drugset / Trial / NCT00913328

Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness

NCT00913328

Phase 4 Completed 31 enrolled Hvidovre University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Leukotriene receptor antagonists appear to posses additive anti-inflammatory effects to the effect of inhaled corticosteroids. Hypothesis: Treatment with oral montelukast will lower the dose-response plateau to inhaled methacholine in patients with mild to moderate persistent asthma treated with a stable dose of inhaled corticosteroids.

Timeline

Start
2002-08
Primary completion
2006-05
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral

Indications